The USPTO will host its first Clean Technology Partnership Meeting on Wednesday, April 27, 2011 in an effort to bring clean technology leaders together to share insights and ideas and provide perspective on how the USPTO can expand its clean technology programs. Foley’s J. Steven Rutt, Chair of the Nanotechnology Team and member of the Green Energy Technologies Team, will moderate the forum and lead a discussion on cleantech innovation, sharing insights from the firm’s soon-to-be released 2011 Annual Cleantech Patent Landscape Report.
Additional speakers include:
- Bruce Kisliuk, Assistant Deputy Commissioner for Patents, Mechanical Disciplines, USPTO
- Jacqueline Stone, Group Director TC 1600, USPTO
- Neil Feltham, Senior Patent Counsel, DuPont
- William S. Elias, General Counsel, UChicago Argonne, LLC
- Mike Nelson, Chief Technology Officer, NanoInk, Inc.
- Alan Brown, Executive Director, Pennsylvania NanoMaterials Commercialization Center
The meeting will be held at USPTO Headquarters in Alexandria, Virginia, from 1:00-5:00 p.m.
Related Insights
July 23, 2025
Foley Viewpoints
The One Big Beautiful Bill and Workplace Immigration Enforcement
The “One Big Beautiful Bill Act,” signed into law by President Trump on July 4, 2025, will fund government efforts to continue to…
July 23, 2025
Health Care Law Today
Update: CMS Extends Skilled Nursing Facilities’ Medicare Revalidation Deadline
On April 17, 2025, the Centers for Medicare and Medicaid Services (CMS) announced another extension of the deadline by which skilled nursing facilities (SNFs) must revalidate their Medicare enrollments.
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).